Liminal BioSciences
(NASDAQ) LMNL
This security has been delisted. This page is retained for historical reference.
LMNL News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowLMNL Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-82%
Net Income Margin
-72%
Return on Equity
-73%
Return on Capital
-82%
Return on Assets
-57%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
CA$401.00K
Operating Income
-CA$32.98M
EBITDA
-CA$31.86M
Operating Cash Flow
-CA$31.82M
Capital Expenditure
-CA$19.00K
Free Cash Flow
-CA$31.84M
Cash & ST Invst.
CA$37.14M
Total Debt
CA$1.49M
Liminal BioSciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CA$112.00K
-28.7%
Gross Profit
CA$112.00K
-28.7%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
251
N/A
Net Income
-CA$9.14M
-192.2%
EBITDA
-CA$8.86M
-65.6%
Quarterly Fundamentals
Net Cash
CA$18.11M
-44.6%
Accounts Receivable
CA$788.00K
-46.8%
Inventory
CA$0.00
N/A
Long Term Debt
CA$528.00K
-96.1%
Short Term Debt
CA$679.00K
-92.9%
Return on Assets
-57.31%
N/A
Return on Invested Capital
-81.71%
N/A
Free Cash Flow
-CA$7.78M
-14.6%
Operating Cash Flow
-CA$7.78M
-14.8%